BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25997625)

  • 1. Identify Potential Regulators in HIV-1 Latency by Joint microRNA and mRNA Analysis.
    Yang Z; Yang J; Wang J; Lu X; Jin C; Xie T; Wu N
    Cell Physiol Biochem; 2015; 36(2):569-84. PubMed ID: 25997625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
    Krishnan V; Zeichner SL
    J Virol; 2004 Sep; 78(17):9458-73. PubMed ID: 15308739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
    Kanak M; Alseiari M; Balasubramanian P; Addanki K; Aggarwal M; Noorali S; Kalsum A; Mahalingam K; Pace G; Panasik N; Bagasra O
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):532-45. PubMed ID: 20502318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput sequencing identifies HIV-1-replication- and latency-related miRNAs in CD4
    Lu X; Yang J; Wu H; Yang Z; Jin C; Wang J; Cheng L; Peng X; Liu F; Peng X; Ji S; Ou H; Xie T; Yao H; Wu N
    Arch Virol; 2017 Jul; 162(7):1933-1942. PubMed ID: 28303346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of microRNAs in HIV-1 Replication and Latency.
    Sun B; Yang R; Mallardo M
    Microrna; 2016; 5(2):120-123. PubMed ID: 27572460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cellular microRNAs, miR-196b and miR-1290, contribute to HIV-1 latency.
    Wang P; Qu X; Zhou X; Shen Y; Ji H; Fu Z; Deng J; Lu P; Yu W; Lu H; Zhu H
    Virology; 2015 Dec; 486():228-38. PubMed ID: 26469550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts.
    Duskova K; Nagilla P; Le HS; Iyer P; Thalamuthu A; Martinson J; Bar-Joseph Z; Buchanan W; Rinaldo C; Ayyavoo V
    BMC Infect Dis; 2013 May; 13():250. PubMed ID: 23721325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of HIV-1-specific cascaded microRNA-mRNA regulatory relationships by parallel mRNA and microRNA expression profiling with AIDS patients after antiviral treatment.
    Shen F; Liu Y; Wang L; Chai X; Yang J; Feng Q; Li X
    Medicine (Baltimore); 2021 Nov; 100(44):e27428. PubMed ID: 34871208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Molecular Biology of HIV Latency.
    Khoury G; Darcis G; Lee MY; Bouchat S; Van Driessche B; Purcell DFJ; Van Lint C
    Adv Exp Med Biol; 2018; 1075():187-212. PubMed ID: 30030794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-l and the microRNA-guided silencing pathway: an intricate and multifaceted encounter.
    Provost P; Barat C; Plante I; Tremblay MJ
    Virus Res; 2006 Nov; 121(2):107-15. PubMed ID: 16889864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of microRNA-silencing pathway by HIV-1 during virus replication.
    Triboulet R; Mari B; Lin YL; Chable-Bessia C; Bennasser Y; Lebrigand K; Cardinaud B; Maurin T; Barbry P; Baillat V; Reynes J; Corbeau P; Jeang KT; Benkirane M
    Science; 2007 Mar; 315(5818):1579-82. PubMed ID: 17322031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
    Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
    Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.
    Munier S; Delcroix-Genête D; Carthagéna L; Gumez A; Hazan U
    Retrovirology; 2005 Nov; 2():73. PubMed ID: 16305739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel genes associated with HIV-1 latency by analysis of histone modifications.
    Kim KC; Lee S; Son J; Shin Y; Yoon CH; Kang C; Choi BS
    Hum Genomics; 2017 May; 11(1):9. PubMed ID: 28499422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underlying mechanisms of HIV-1 latency.
    Romani B; Allahbakhshi E
    Virus Genes; 2017 Jun; 53(3):329-339. PubMed ID: 28258391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference and HIV-1 infection.
    Kanzaki LI; Ornelas SS; Argañaraz ER
    Rev Med Virol; 2008; 18(1):5-18. PubMed ID: 17764099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control.
    Heinson AI; Woo J; Mukim A; White CH; Moesker B; Bosque A; Spina CA; Woelk CH; Macarthur BD; Beliakova-Bethell N
    AIDS Res Hum Retroviruses; 2021 Feb; 37(2):109-121. PubMed ID: 33045840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.